MARKET

ORYZF

ORYZF

Oryzon Genomics
OTCPK
3.450
NaN%
Opening 09:30 09/11 EDT
OPEN
--
PREV CLOSE
3.450
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
3.450
52 WEEK LOW
1.620
MARKET CAP
267.44M
P/E (TTM)
-98.0114
1D
5D
1M
3M
1Y
5Y
1D
Oryzon Genomics: Advancing LSD1 Pipeline and Strong Cash Position Support Unchanged $10 Price Target and Buy Rating
TipRanks · 07/30 00:15
Oryzon Genomics Restates 2025 Interim Results After Accounting Policy Change
TipRanks · 07/28 14:23
Roth MKM Sticks to Their Buy Rating for Oryzon Genomics SA (ORN)
TipRanks · 07/28 13:46
Oryzon Genomics Updates Loyalty Share Voting Rights Structure
TipRanks · 07/22 13:23
Oryzon Genomics Completes €12 Million Share Capital Increase
TipRanks · 07/07 12:03
Oryzon Genomics Raises €12 Million Through Discounted Private Share Placement
TipRanks · 07/02 11:16
Oryzon Genomics Shareholders Approve All Resolutions at 2026 General Meeting
TipRanks · 07/02 11:13
Oryzon Genomics launches capital raise and secures €25m anchor commitment for R&D
TipRanks · 07/01 11:21
More
About ORYZF
Oryzon Genomics SA, is a Spain-based clinical phase biopharmaceutical company, which discovers and develops drugs based on epigenetics for the treatment of oncological and neurological diseases. Its compounds in clinical development include iadademstat (ORY-lOOl), an LSD1 inhibitor that is in Phase II trials for the treatment of acute myeloid leukemia and small cell lung cancer; and vafidemstat (ORY-2001), an LSD1 inhibitor optimized for the Central Nervous System (CNS), in multiple Phase II clinical trials for the treatment of CNS and psychiatric illnesses. The Company also has ORY-3001, in preclinical development for the treatment of non-oncological diseases and has additional programs to develop inhibitors against other epigenetic targets.

Webull offers Oryzon Genomics SA stock information, including OTCPK: ORYZF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ORYZF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ORYZF stock methods without spending real money on the virtual paper trading platform.